Disc Medicine suspends remaining $80M ATM equity program; plans public offering

Disc Medicine, Inc.

Suspended at-the-market stock offering under Sales Agreement with SVB Securities; $20M of $100M previously sold.
Suspension is in connection with a proposed registered underwritten public offering.
Sales Agreement remains in effect; no further sales until new prospectus or registration statement filed.
No other details on the new public offering (size, price, timing) disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.